Growth Metrics

Catalyst Pharmaceuticals (CPRX) Amortizatization of Intangibles: 2022-2025

Historic Amortizatization of Intangibles for Catalyst Pharmaceuticals (CPRX) over the last 3 years, with Sep 2025 value amounting to $9.3 million.

  • Catalyst Pharmaceuticals' Amortizatization of Intangibles fell 0.01% to $9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.4 million, marking a year-over-year increase of 0.77%. This contributed to the annual value of $37.4 million for FY2024, which is 14.78% up from last year.
  • According to the latest figures from Q3 2025, Catalyst Pharmaceuticals' Amortizatization of Intangibles is $9.3 million, which was down 0.00% from $9.3 million recorded in Q2 2025.
  • Catalyst Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $9.3 million during Q3 2024, with a 5-year trough of $580,000 in Q4 2022.
  • For the 3-year period, Catalyst Pharmaceuticals' Amortizatization of Intangibles averaged around $8.9 million, with its median value being $9.3 million (2025).
  • In the last 5 years, Catalyst Pharmaceuticals' Amortizatization of Intangibles skyrocketed by 1,461.90% in 2023 and then decreased by 0.01% in 2025.
  • Over the past 4 years, Catalyst Pharmaceuticals' Amortizatization of Intangibles (Quarterly) stood at $580,000 in 2022, then surged by 1,461.90% to $9.1 million in 2023, then grew by 3.15% to $9.3 million in 2024, then decreased by 0.01% to $9.3 million in 2025.
  • Its Amortizatization of Intangibles was $9.3 million in Q3 2025, compared to $9.3 million in Q2 2025 and $9.3 million in Q1 2025.